Intimation about incorporation of Wholly owned step-down subsidiary in India.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has set up a new step-down subsidiary called Pivot Path Private Limited, incorporated on April 10, 2025, with CIN U74900KA2025PTC201082. The new entity is 100% owned by Arco Lab Private Limited, which itself is a wholly owned subsidiary of Strides. Pivot Path has an authorized share capital of Rs. 10 lakh and subscribed capital of Rs. 1 lakh, paid in cash at par. The company will focus on outsourcing and business support services with an emphasis on the pharmaceutical sector, and specifically on life sciences and manufacturing solutions. Strides plans to transfer its Life Sciences and Digital Innovation capabilities from Arco Lab to Pivot Path through a Scheme of Arrangement under the Companies Act, 2013, though details of that scheme are yet to be communicated.
This is an internal group restructuring rather than an external deal, so direct impact on shareholders is limited. Investors should watch for further updates on the proposed Scheme of Arrangement, which could signal a more meaningful reorganization of Strides' digital and life sciences businesses.